Lithium News

RSS
Medaro Announces Phase 1 Exploration Program Results on Darlin Lithium Property in Quebec

Medaro Announces Phase 1 Exploration Program Results on Darlin Lithium Property in Quebec

Piedmont Lithium Partner Sayona Announces Positive NAL DFS and Increased Resource at Moblan

Piedmont Lithium Partner Sayona Announces Positive NAL DFS and Increased Resource at Moblan

Beyond Minerals Enters Agreement for Grassroots Lithium Exploration

Beyond Minerals Enters Agreement for Grassroots Lithium Exploration

Medaro Mining Submits Patent Applications for Spodumene Processing Technology

Medaro Mining Submits Patent Applications for Spodumene Processing Technology

Gold Lion Involves Geologica as Its Technical Fieldwork Partner for 2023 Campaign at Mia Li-3 Lithium Project

Gold Lion Involves Geologica as Its Technical Fieldwork Partner for 2023 Campaign at Mia Li-3 Lithium Project

Medaro Mining Selects Site for Its First Pilot Plant

Medaro Mining Selects Site for Its First Pilot Plant

Pan American Partners with Integrity Mining and Industrial to Enhance Lithium Production and Recovery

Pan American Partners with Integrity Mining and Industrial to Enhance Lithium Production and Recovery

Tamino Announces Acquisition of New Lithium Claims in South America

Tamino Announces Acquisition of New Lithium Claims in South America

Goat Industries Signs Two Separate Asset Purchase Agreements to Acquire the Lacana-Doran Claim Blocks

Goat Industries Signs Two Separate Asset Purchase Agreements to Acquire the Lacana-Doran Claim Blocks

Advance Lithium Reaches an Agreement to Acquire 100% of Wolfden’s Claims in the Bathurst Mining Camp

Advance Lithium Reaches an Agreement to Acquire 100% of Wolfden’s Claims in the Bathurst Mining Camp

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.